Terbinafine Treatment Duration
For toenail onychomycosis (the most common indication), prescribe terbinafine 250 mg daily for 12 weeks; for fingernail onychomycosis, prescribe 6 weeks of treatment. 1, 2
Standard Treatment Durations by Indication
Onychomycosis (Nail Infections)
- Toenail infections: 12 weeks of continuous therapy is the evidence-based standard duration 1, 2, 3
- Fingernail infections: 6 weeks of continuous therapy is sufficient 1, 2, 4
- The British Association of Dermatologists designates terbinafine as the first-line treatment for dermatophyte onychomycosis with strength of recommendation A, level of evidence 1+ 1
Tinea Capitis (Scalp Ringworm) - Pediatric Dosing
- Duration: 2-4 weeks depending on causative organism 5
- Weight-based dosing 5, 6:
- <20 kg: 62.5 mg daily
- 20-40 kg: 125 mg daily
40 kg: 250 mg daily (adult dose)
- Important caveat: Terbinafine is highly effective against Trichophyton species but significantly less effective against Microsporum species—griseofulvin is superior for Microsporum infections 1
Why These Specific Durations Matter
Pharmacokinetic Rationale
- Terbinafine is detected in the nail within 1 week of starting therapy and persists for 6 months after treatment completion due to its long half-life and lipophilic properties 1
- This prolonged tissue persistence allows for continued fungicidal activity even after stopping the medication 7, 8
- The drug accumulates in keratin-rich tissues (nails, hair, skin) and maintains therapeutic concentrations long after plasma clearance 9
Evidence Against Shorter Durations for Toenails
- A randomized trial comparing 6,12, and 24 weeks of treatment showed complete cure rates at final follow-up of 40% (6 weeks), 71% (12 weeks), and 79% (24 weeks) 3
- Six weeks is generally insufficient for toenail infections, even when the proximal nail matrix is not involved, with cure rates of only 45.9% compared to 58.9% with 12 weeks 4
- The marginal benefit of extending beyond 12 weeks to 24 weeks does not justify the additional drug exposure and cost 3
Pre-Treatment and Monitoring Requirements
Mandatory Baseline Testing
- Obtain liver function tests (ALT and AST) before initiating treatment in all patients 6, 2
- Complete blood count is recommended, particularly in patients with history of hepatitis, heavy alcohol use, or hematological abnormalities 1
- Confirm fungal infection with mycological testing (KOH preparation and/or culture) before starting therapy 2
Absolute Contraindications
- Active or chronic liver disease 1, 6, 2
- Lupus erythematosus 1, 6, 2
- Known hypersensitivity to oral terbinafine 2
Critical Safety Warnings
Permanent Adverse Effects
- Taste disturbance occurs in approximately 1 in 400 patients and can be permanent—patients must be explicitly warned of this risk before starting treatment 10, 2
- Loss of smell may also occur and can become permanent 2
Serious But Rare Complications
- Hepatotoxicity can lead to liver failure requiring transplantation or resulting in death 2
- Patients should immediately report nausea, vomiting, right upper quadrant pain, jaundice, dark urine, or pale stools 2
- Stevens-Johnson syndrome and toxic epidermal necrolysis have been reported 1
- New-onset or worsening lupus erythematosus requires immediate discontinuation 2
When to Assess Treatment Response
- Evaluate response 3-6 months after initiating treatment, not at the end of the treatment course 5
- This delayed assessment accounts for the time required for normal nail growth and the drug's persistent antifungal activity after treatment completion 1, 7
- Mycological cure rates continue to improve after treatment cessation due to terbinafine's fungicidal mechanism 8
Drug Interaction Considerations
- Terbinafine has minimal drug-drug interactions compared to azole antifungals, making it safer for patients on multiple medications 1, 10
- The only potentially significant interaction involves drugs metabolized by cytochrome P450 2D6 (e.g., certain antidepressants, beta-blockers, antiarrhythmics) 1, 6
- Unlike itraconazole, terbinafine does not interact with warfarin, statins, antihistamines, or most other commonly prescribed medications 10
Practical Prescribing Details
- Dosing: 250 mg once daily for adults 1, 2
- Can be taken with or without food—absorption is not affected by food intake 1
- If a dose is missed, take as soon as remembered unless less than 4 hours remain before the next scheduled dose 2
- Advise patients to minimize sun exposure and use sun protection, as photosensitivity reactions can occur 2